Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses.
Employment range in NC
Primary site activity
All company activities
Products under development
Vaccines targeting infections caused by herpesviruses such as Cytomegaloirus and Epstein-Barr virus